FIA president Mohammed Ben Sulayem says he would like Formula 1 cars to weigh as little as 630kg in the championship's next ...

The results of two phase 3 trials investigating Survodutide, a weight loss drug from Boehringer Ingelheim, suggest that the ...

A NEW injection, dubbed the “Godzilla” of weight loss jabs, could combat snoring and knee pain on top of triggering fat loss.

CicadaBio today announced that new preclinical data for CC-18, its investigational GLP-1/anti-ActRII dual-pathway fusion ...

Semaglutide is an injectable drug formulated for the treatment of type 2 diabetes, but it’s since become increasingly popular ...

A study found that mazdutide, a once-weekly glucagon and GLP-1 receptor dual agonist, led to clinically meaningful weight ...

In a clinical trial, the new weight-loss medication retatrutide led to "clinically meaningful weight reduction," with the highest dose linked to a 30% reduction in average body weight ...

A new study shows those who took retatrutide lost a whopping 28% of their body weight after 80 weeks, similar to weight loss from bariatric surgery.

Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial showed targeted 34% visceral and 63% liver fat ...